<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский журнал клинической и экспериментальной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian Journal of Clinical and Experimental Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-2927</issn><issn pub-type="epub">2713-265X</issn><publisher><publisher-name>TSU publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29001/2073-8552-2022-37-3-128-135</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiotomsk-1514</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Влияние экстрактов растений на инсулинорезистентность при экспериментальном сахарном диабете</article-title><trans-title-group xml:lang="en"><trans-title>Influence of plant extracts on insulin resistance in experimental diabetes mellitus</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3330-660X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дымбрылова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Dymbrylova</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дымбрылова Очирма Насаковна, канд. мед. наук, младший научный сотрудник отделения клинической лабораторной диагностики</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>Ochirma N. Dymbrylova, Cand. Sci. (Med.), Junior Researcher, Department of Clinical Laboratory Diagnostics</p><p>111a, Kievskaya str., Tomsk, 634012</p></bio><email xlink:type="simple">o.nasanova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0530-8656</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Якимова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakimova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Якимова Татьяна Витальевна, канд. мед. наук, доцент кафедры фармакологии</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>Tatyana V. Yakimova, Cand. Sci. (Med.), Associate Professor, Department of Pharmacology</p><p>2, Moskovsky tract, Tomsk, 634050</p></bio><email xlink:type="simple">t-yakimova@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5094-3742</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Венгеровский</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vengerovskii</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Венгеровский Александр Исаакович, д-р мед. наук, профессор кафедры фармакологии</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>Aleksandr I. Vengerovskii, Dr. Sci. (Med.), Professor, Department of Pharmacology</p><p>2, Moskovsky tract, Tomsk, 634050</p></bio><email xlink:type="simple">pharm-sibgmu@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2022</year></pub-date><volume>37</volume><issue>3</issue><fpage>128</fpage><lpage>135</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дымбрылова О.Н., Якимова Т.В., Венгеровский А.И., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Дымбрылова О.Н., Якимова Т.В., Венгеровский А.И.</copyright-holder><copyright-holder xml:lang="en">Dymbrylova O.N., Yakimova T.V., Vengerovskii A.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibjcem.ru/jour/article/view/1514">https://www.sibjcem.ru/jour/article/view/1514</self-uri><abstract><p>Цель исследования: оценить влияние экстрактов лекарственных растений на чувствительность к инсулину на животной модели сахарного диабета.Материал и методы. Эксперименты проведены на 110 аутбредных белых крысах-самцах. Сахарный диабет индуцировали введением стрептозотоцина животным, получавшим пищу с высоким содержанием жиров для формирования инсулинорезистентности. Животным вводили водные экстракты крапивы, одуванчика, лопуха, галеги лекарственной, метформин, росиглитазон. При проведении фармакотерапии крыс разделили на 2 группы: одна продолжала получать обогащенную жирами диету, другая – обычный пищевой рацион с содержанием жиров 8%. В крови измеряли уровень глюкозы, гликогемоглобина, триглицеридов, холестерина липопротеинов высокой плотности. Для оценки инсулинорезистентности использовали расчетный показатель – метаболический индекс.Результаты. У животных с моделью сахарного диабета, получавших обогащенную жирами пищу, экстракты крапивы, лопуха снижали концентрацию глюкозы и гликогемоглобина. Экстракт одуванчика не изменял уровень глюкозы в крови натощак, понижал концентрацию гликогемоглобина. У животных, получавших обычный пищевой рацион, экстракты крапивы, галеги, одуванчика уменьшали концентрацию глюкозы в крови, экстракты всех растений снижали уровень гликогемоглобина. При введении экстрактов растений концентрация триглицеридов нормализовалась независимо от режима питания. У животных, получавших экстракты галеги, одуванчика, концентрация холестерина липопротеинов высокой плотности при обоих вариантах диеты повышалась. После терапии экстрактами крапивы, галеги у животных, получавших пищу с содержанием жиров 8%, метаболический индекс не отличается от показателя интактных крыс. Экстракт одуванчика ослабляет инсулинорезистентность у животных, продолжавших получать диету, обогащенную жирами.Заключение. При сахарном диабете, вызванном введением крысам стрептозотоцина, экстракты крапивы, галеги лекарственной, лопуха, одуванчика в такой же степени, как метформин и росиглитазон, улучшают углеводный, липидный обмены. Экстракты крапивы, галеги ослабляют инсулинорезистентность у животных, получавших обычный пищевой рацион, экстракт одуванчика – у животных, получавших пищу, обогащенную жирами.</p></abstract><trans-abstract xml:lang="en"><p>Objective. The aim of the study was to evaluate the effect of medicinal plant extracts on insulin sensitivity in the model of diabetes mellitus.Material and Methods. Experiments were carried out using 110 outbred white male rats. Diabetes mellitus was induced by the administration of streptozotocin to animals receiving food with a high fat content for the formation of insulin resistance. The animals were injected with metformin, rosiglitazone, and aqueous extracts of nettle, dandelion, burdock, and Galega officinalis. The rats were divided into two groups during pharmacotherapy: group 1 continued to receive fat-enriched diet; group 2 received a regular diet with 8% fat content. The blood levels of glucose, glycated hemoglobin, triglycerides, and high-density lipoprotein cholesterol were measured. The metabolic index was calculated to assess insulin resistance.Results. The extracts of nettle and burdock reduced the concentration of glucose and glycated hemoglobin in animals with a model of diabetes mellitus treated with fat-enriched food. Dandelion extract did not change the level of fasting glucose in blood whereas it lowered the concentration of glycohemoglobin. The extracts of nettle, Galega officinalis, and dandelion reduced blood concentrations of glucose in animals receiving normal diet. The extracts of all plants reduced the level of glycated hemoglobin. The concentration of triglycerides normalized regardless of the diet when plant extracts were introduced. The concentrations of high-density lipoprotein cholesterol increased in both diets in animals treated with Galega officinalis and dandelion extracts. The metabolic index in rats receiving food with 8%-fat content did not differ from that of intact animals after therapy with nettle and Galega officinalis extracts. Dandelion extract alleviated insulin resistance in animals continuing to receive a diet enriched with fats.Conclusion. The extracts of nettle, Galega officinalis, burdock, and dandelion improved carbohydrate and lipid metabolism in diabetes mellitus caused by the administration of streptozotocin to rats to the same extent as metformin and rosiglitazone. Extracts of nettle and Galega officinalis alleviated insulin resistance in animals receiving a normal diet; dandelion extract alleviated insulin resistance in animals receiving fat-enriched food.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инсулинорезистентность</kwd><kwd>модель экспериментального сахарного диабета</kwd><kwd>крапива</kwd><kwd>лопух</kwd><kwd>одуванчик</kwd><kwd>галега</kwd></kwd-group><kwd-group xml:lang="en"><kwd>insulin resistance</kwd><kwd>experimental model of diabetes mellitus</kwd><kwd>nettle</kwd><kwd>burdock</kwd><kwd>dandelion</kwd><kwd>Galega officinalis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Спасов А.А., Петров В.И., Чепляева Н.И., Ленская К.В. Фундаментальные основы поиска лекарственных средств для терапии сахарного диабета 2-го типа. Вестник Российской академии медицинских наук. 2013;(2):43–49. DOI: 10.15690/vramn.v68i2.548.</mixed-citation><mixed-citation xml:lang="en">Spasov A.A., Petrov V.I., Cheplyaeva N.I., Lenskaya K.V. Fundamental bases of search of medicines for therapy of a diabetes mellitus type 2. Annals of the Russian Academy of Medical Sciences. 2013;(2):43–49. (In Russ.). DOI: 10.15690/vramn.v68i2.548.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Салухов В.В., Халимов Ю.Ш., Шустов С.Б., Кадин Д.В. Снижение кардиоваскулярного риска у пациентов с сахарным диабетом второго типа: обзор основных стратегий и клинических исследований. Сахарный диабет. 2018;21(3):193–205. DOI: 10.14341/DM9570.</mixed-citation><mixed-citation xml:lang="en">Salukhov V.V., Khalimov Yu.Sh., Shustov S.B., Kadin D.V. Decrease of cardiovascular risk in patients with type 2 diabetes: Review of the common strategies and clinical studies. Diabetes Mellitus. 2018;21(3):193–205. (In Russ.). DOI: 10.14341/DM9570.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Хабриев Р.У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М.: Медицина; 2005:832.</mixed-citation><mixed-citation xml:lang="en">Habriev R.U. Guideline for experimental (preclinical) studying of new pharmacological substances. Moscow: Meditsina; 2005:832. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M., Lv X., Li J., Xu Z., Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp. Diabetes Res. 2008;2008:704045. DOI: 10.1155/2008/704045.</mixed-citation><mixed-citation xml:lang="en">Zhang M., Lv X., Li J., Xu Z., Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp. Diabetes Res. 2008;2008:704045. DOI: 10.1155/2008/704045.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kawamori D., Kurpad A.J., Hu J., Liew C.W., Shih J.L., Ford E.L. et al. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab. 2009;9(4):350–361. DOI: 10.1016/j.cmet.2009.02.007.</mixed-citation><mixed-citation xml:lang="en">Kawamori D., Kurpad A.J., Hu J., Liew C.W., Shih J.L., Ford E.L. et al. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab. 2009;9(4):350–361. DOI: 10.1016/j.cmet.2009.02.007.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rao R.P., Singh A., Jain A.K., Srinivasan B.P. Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats. J. Biomed. Res. 2011;25(6):411–417. DOI: 10.1016/S1674-8301(11)60054-7.</mixed-citation><mixed-citation xml:lang="en">Rao R.P., Singh A., Jain A.K., Srinivasan B.P. Dual therapy of rosiglitazone/ pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats. J. Biomed. Res. 2011;25(6):411–417. DOI: 10.1016/S1674-8301(11)60054-7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">El-Bassossy H.M., Abo-Warda S.M., Fahmy A. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. Clin. Exp. Pharmacol. Physiol. 2012; 39(8):643–649. DOI: 10.1111/j.1440-1681.2012.05724.x.</mixed-citation><mixed-citation xml:lang="en">El-Bassossy H.M., Abo-Warda S.M., Fahmy A. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. Clin. Exp. Pharmacol. Physiol. 2012;39(8):643–649. DOI: 10.1111/j.1440-1681.2012.05724.x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Венгеровский А.И., Якимова Т.В., Насанова О.Н. Гиполипидемическое действие экстрактов лекарственных растений при экспериментальном сахарном диабете. Химико-фармацевтический журнал. 2019;53(3):40–44. DOI: 10.30906/0023-1134-2019-53-3-40-44.</mixed-citation><mixed-citation xml:lang="en">Vengerovskii A.I., Yakimova T.V., Nasanova O.N. Hypolipidemic action of nettle and burdock herbal extracts in experimental diabetes mellitus. Pharmaceutical Chemistry Journal. 2019;53(3):40–44. (In Russ.). DOI: 10.30906/0023-1134-2019-53-3-40-44.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Якимова Т.В., Насанова О.Н., Венгеровский А.И., Буркова В.Н. Влияние экстракта галеги лекарственной на метаболизм липидов при экспериментальном сахарном диабете. Сибирский медицинский журнал. 2011;26(4):98–102.</mixed-citation><mixed-citation xml:lang="en">Yakimova T.V., Nasanova O.N., Vengerovskii A.I., Burkova V.N. Infl uence of Galega extracts on lipids metabolism in experimental diabetes mellitus. Siberian Medical Journal. 2011; 26(4):98–102. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ройтберг Г.Е., Дорош Ж.В., Шархун О.О., Ушакова Т.И., Трубино Е.А. Возможности применения нового метаболического индекса при оценке инсулинорезистентности в клинической практике. Рациональная Фармакотерапия в Кардиологии. 2014;10(3):264–274.</mixed-citation><mixed-citation xml:lang="en">Rojtberg G.E., Dorosh Zh.V., Sharhun O.O., Ushakova T.I., Trubino E.A. New metabolic index use potentialities in evaluation of insulin resistance in clinical practice. Rational Pharmacotherapy in Cardiology. 2014;10(3):264–274. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Хафизьянова Р.Х., Бурыкин И.М., Алеева Г.Н. Математическая статистика в экспериментальной фармакологии. Казань: Медицина; 2006:373.</mixed-citation><mixed-citation xml:lang="en">Khafi z’yanova R.Kh., Burykin I.M., Aleeva G.N. Mathematical statistics in experimental pharmacology. Kazan: Meditsina; 2006:374. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Горбунов Е.А., Бригадирова А.А., Качаева Е.В., Путиловский М.А., Тарасов С.А. Перспективные фармакологические мишени для лечения заболеваний, сопряженных с дефектом сигнального пути рецептора инсулина. Проблемы эндокринологии. 2015;61(6):36–43.</mixed-citation><mixed-citation xml:lang="en">Gorbunov E.A., Brigadirova A.A., Kachaeva E.V., Putilovskii M.A., Tarasov S.A. Promising pharmacological targets for the treatment of the diseases associated with the impaired insulin receptor signaling pathway. Problems of Endocrinology. 2015;61(6):36–43. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Behl T., Gupta A., Sehgal A., Albarrati A., Albratty M., Meraya A.M. et al. Exploring protein tyrosine phosphatases (PTP) and PTP-1B inhibitors in management of diabetes mellitus. Biomed. Pharmacother. 2022;153:113405. DOI: 10.1016/j.biopha.2022.113405.</mixed-citation><mixed-citation xml:lang="en">Behl T., Gupta A., Sehgal A., Albarrati A., Albratty M., Meraya A.M. et al. Exploring protein tyrosine phosphatases (PTP) and PTP-1B inhibitors in management of diabetes mellitus. Biomed. Pharmacother. 2022;153:113405. DOI: 10.1016/j.biopha.2022.113405.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Uddin Z., Song Y.H., Ulla M., Li Z., Kim J.Y., Park K.H. Isolation and characterization of protein tyrosine phosphatase 1B (PTP1B) inhibitory polyphenolic compounds from Dodonaea viscosa and their kinetic analysis. Front. Chem. 2018;6(40):1–10. DOI: 10.3389/fchem.2018.00040.</mixed-citation><mixed-citation xml:lang="en">Uddin Z., Song Y.H., Ulla M., Li Z., Kim J.Y., Park K.H. Isolation and characterization of protein tyrosine phosphatase 1B (PTP1B) inhibitory polyphenolic compounds from Dodonaea viscosa and their kinetic analysis. Front. Chem. 2018;6(40):1–10. DOI: 10.3389/fchem.2018.00040.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Akhtar M.S., Ahmed M., Gulzar K., Adnan H. Hypoglycaemic activity of Dodonaeae viscosa leaves normal and alloxan-induced diabetic rabbits. Diabetologia Croatica. 2011;40(3):71–79.</mixed-citation><mixed-citation xml:lang="en">Akhtar M.S., Ahmed M., Gulzar K., Adnan H. Hypoglycaemic activity of Dodonaeae viscosa leaves normal and alloxan-induced diabetic rabbits. Diabetologia Croatica. 2011;40(3):71–79.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Tamrakar A.K., Yadav P.P., Tiwari P., Maurya R., Srivastava A.K. Identifi cation of pongamol and karanjin as lead compounds with antihyperglycemic activity from Pongamia pinnata fruits. J. Ethnopharmacol. 2008;118(3):435–439. DOI: 10.1016/j.jep.2008.05.008.</mixed-citation><mixed-citation xml:lang="en">Tamrakar A.K., Yadav P.P., Tiwari P., Maurya R., Srivastava A.K. Identifi cation of pongamol and karanjin as lead compounds with antihyperglycemic activity from Pongamia pinnata fruits. J. Ethnopharmacol. 2008;118(3):435–439. DOI: 10.1016/j.jep.2008.05.008.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Belete T.M. A Recent achievement in the discovery and development of novel targets for the treatment of type-2 diabetes mellitus. J. Exp. Pharmacol. 2020;12:1–15. DOI: 10.2147/JEP.S226113.</mixed-citation><mixed-citation xml:lang="en">Belete T.M. A Recent achievement in the discovery and development of novel targets for the treatment of type-2 diabetes mellitus. J. Exp. Pharmacol. 2020;12:1–15. DOI: 10.2147/JEP.S226113.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hu T., Shi J.J., Fang J., Wang Q., Chen Y.B., Zhang S.J. Quercetin ameliorates diabetic encephalopathy through SIRT1/ER stress pathway in db/db mais. Aging (Albany NY). 2020;12(8):7015–7029. DOI: 10.18632/aging.103059.</mixed-citation><mixed-citation xml:lang="en">Hu T., Shi J.J., Fang J., Wang Q., Chen Y.B., Zhang S.J. Quercetin ameliorates diabetic encephalopathy through SIRT1/ER stress pathway in db/db mais. Aging (Albany NY). 2020;12(8):7015–7029. DOI: 10.18632/aging.103059.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Curry A.M., White D.S., Donu D., Cen Y. Human sirtuin regulators: The “Success” stories. Front. Physiol. 2021;12:752117. DOI: 10.3389/fphys.2021.752117.</mixed-citation><mixed-citation xml:lang="en">Curry A.M., White D.S., Donu D., Cen Y. Human sirtuin regulators: The “Success” stories. Front. Physiol. 2021;12:752117. DOI: 10.3389/fphys.2021.752117.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Huynh F.K., Hershberger K.A., Hirschey M.D. Targeting sirtuins for the treatment of diabetes. Diabetes Manag. (Lond.). 2013;3(3):245–257. DOI: 10.2217/dmt.13.6.</mixed-citation><mixed-citation xml:lang="en">Huynh F.K., Hershberger K.A., Hirschey M.D. Targeting sirtuins for the treatment of diabetes. Diabetes Manag. (Lond.). 2013;3(3):245–257. DOI: 10.2217/dmt.13.6.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
